Breaking News, Collaborations & Alliances

Endo, Jubilant Expand Oncology Pact

Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals have expanded their drug discovery partnership in oncology, following the delivery of an early stage milestone.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals have expanded their drug discovery partnership in oncology, following the delivery of an early stage milestone. Jubilant focuses on delivering preclinical oncology candidates while Endo owns the late-stage development and commercialization rights for any molecules discovered. Jubilant receives research funding and success-based development and commercialization milestones. Sri Mosur, chief executive off...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters